Ownership history in ROYCE & ASSOCIATES LP · 9 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in Charles River Laboratories Intl COM (CRL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 84,361 | -1,279 | -1.5% | 0.13% | $13.2M | $156.46 |
| 2025 Q2 | ADDED | 85,640 | +81,500 | +1968.6% | 0.13% | $13.0M | $151.73 |
| 2025 Q1 | REDUCED | 4,140 | -11,452 | -73.4% | 0.01% | $623K | $150.52 |
| 2024 Q1 | ADDED | 15,592 | +1,617 | +11.6% | 0.04% | $4.2M | $270.95 |
| 2023 Q4 | ADDED | 13,975 | +13,605 | +3677.0% | 0.03% | $3.3M | $236.40 |
| 2008 Q2 | UNCHANGED | 370 | — | 0% | 0.00% | $24K | $63.92 |
| 2008 Q1 | ADDED | 370 | +100 | +37.0% | 0.00% | $22K | $58.94 |
| 2007 Q4 | REDUCED | 270 | -19,730 | -98.7% | 0.00% | $18K | $65.80 |
| 2005 Q3 | INITIATED | 20,000 | — | — | 0.00% | $872K | $43.62 |
As of 2025 Q4 — sorted by position size